HYPERION DEFI, INC.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
295 MADISON AVENUE, NEW YORK, NY, 10017
Mailing Address
295 MADISON AVENUE, NEW YORK, NY, 10017
Phone
833-393-6684
Fiscal Year End
1231
EIN
471178401
Financial Overview
FY2025
$-9.40
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | April 1, 2026 | View on SEC |
| 4 Insider stock transaction report | April 1, 2026 | View on SEC |
| 10-K Annual financial report | March 30, 2026 | View on SEC |
| 8-K Current report of material events | March 26, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 3, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 11, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 5, 2026 | View on SEC |
| 4 Insider stock transaction report | January 12, 2026 | View on SEC |
| 3 Initial insider ownership report | January 12, 2026 | View on SEC |
| 8-K Current report of material events | January 5, 2026 | View on SEC |
Annual Reports
10-K
March 30, 2026
- Successful pivot from medical-tech to a hybrid crypto-validator model.
- Operates a significant validator node, 'Kinetiq x Hyperion', with over 11 million HYPE tokens staked.
Insider Trading
STRONG BUY
4 insiders
9 recent transactions
View Insider Trading Dashboard
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.